Prognosis, a New Show From Bloomberg

More than a million Americans suffer from Type 1 diabetes. The disease occurs when the pancreas mysteriously stops producing insulin, the hormone that converts food into energy. Modern medicine has been able to recreate insulin, but not the finely calibrated delivery mechanism of ...  Show more

If you had told people from the 1970s that few decades later the globe would be connected with powerful computers held in the palm of your hand, they could be forgiven for thinking you were seriously deluded. Now, a growing number of scientists are convinced we're on a similar th ...  Show more

How will we detect disease in the future, and how might new technology aid our well-being? In this episode, Dr. Oz sits down with entrepreneur Peter Diamandis and former FDA commissioner Rob Califf inside The Vatican to uncover the truth about the future of medicine. From the lat ...  Show more

Geroscience aims to define and modify biologic pathways associated with aging and age-related diseases. Author Stephen B. Kritchevsky, PhD, of the Wake Forest University School of Medicine and JAMA Deputy Editor Mary M. McDermott, MD, discuss current evidence regarding geroscienc ...  Show more

Smitha Mundasad asks whether we will see waves of Covid – with infections going up and down and then up and down again - forever more. We speak to Elliot whose life has been transformed after a single shot of gene therapy to treat the inherited blood disorder haemophilia B. And D ...  Show more

As a number of existing therapies are being re-purposed to help patients with the most severe Covid-19 symptoms, we speak to a UK-based bioscience company about a drug they've developed and explore how it is being used in Italy. Guests: Tom Whipple, The Times science editorSomeit ...  Show more